The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
γ-Hydroxybutyric Acid
Abstract
The short-chain fatty acid γ-hydroxybutyric acid (GHB), which is synthesized as an analogue of γ-aminobutyric acid (GABA) that would cross the blood–brain barrier, has found limited clinical use as an anesthetic agent and as treatment for narcolepsy and alcoholism. However, during the past decade, GHB has emerged as a major recreational drug in the United States. This review article discusses the mechanisms of action and presents an approach to the treatment of overdose, abuse, and addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Is there more to gaba than synaptic inhibition?
Owens, D. F., & Kriegstein, A. R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn919 · Cited by 1,156
Molecular Structure and Physiological Functions of GABABReceptors
Bettler, B., Kaupmann, K., Mosbacher, J., & Gassmann, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00036.2003 · Cited by 924
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
THE γ-HYDROXYBUTYRATE SIGNALLING SYSTEM IN BRAIN: ORGANIZATION AND FUNCTIONAL IMPLICATIONS
MAITRE, M. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00064-0 · Cited by 453
Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system
Cruz, H. G., Ivanova, T., Lunn, M.-L., Stoffel, M., Slesinger, P. A., & Lüscher, C. (2004) · Nature Neuroscience · doi:10.1038/nn1181 · Cited by 367
Prevalence of Drugs Used in Cases of Alleged Sexual Assault
ElSohly, M. A., & Salamone, S. J. (1999) · Journal of Analytical Toxicology · doi:10.1093/jat/23.3.141 · Cited by 298
Laborit, H. (1964) · International Journal of Neuropharmacology · doi:10.1016/0028-3908(64)90074-7 · Cited by 251
Clinical Course of γ-Hydroxybutyrate Overdose
Chin, R. L., Sporer, K. A., Cullison‡, B., Dyer, J. E., & Wu, T. D. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70230-6 · Cited by 245
GABAB receptor agonists for the treatment of drug addiction: a review of recent findings
Cousins, M. S., Roberts, D. C. S., & Wit, H. D. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240
Drug-Facilitated Sexual Assault (‘Date Rape’)
SCHWARTZ, R. H., MILTEER, R., & LeBEAU, M. A. (2000) · Southern Medical Journal · doi:10.1097/00007611-200006000-00002 · Cited by 236
Adverse Events, Including Death, Associated with the Use of 1,4-Butanediol
Zvosec, D. L., Smith, S. W., McCutcheon, J. R., Spillane, J., Hall, B. J., & Peacock, E. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440202 · Cited by 235
Van Cauter, E., Plat, L., Scharf, M. B., Leproult, R., Cespedes, S., L'Hermite-Balériaux, M., & Copinschi, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119587 · Cited by 234
Smith, K. M., Larive, L. L., & Romanelli, F. (2002) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/59.11.1067 · Cited by 225
The effects and consequences of selected club drugs
Freese, T. E., Miotto, K., & Reback, C. J. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00267-2 · Cited by 217
Gamma-hydroxybutyrate withdrawal syndrome
Dyer, J. E., Roth, B., & Hyma, B. A. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.112985 · Cited by 197
SGS742: the first GABAB receptor antagonist in clinical trials
Froestl, W., Gallagher, M., Jenkins, H., Madrid, A., Melcher, T., Teichman, S., Mondadori, C. G., & Pearlman, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.030 · Cited by 193
γ-Hydroxybutyrate is a weak agonist at recombinant GABAB receptors
Lingenhoehl, K. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00131-8 · Cited by 192
Gamma‐Hydroxybutyric Acid: Patterns of Use, Effects and Withdrawal
Miotto, K., Darakjian, J., Basch, J., Murray, S., Zogg, J., & Rawson, R. (2001) · The American Journal on Addictions · doi:10.1080/105504901750532111 · Cited by 191
Kaupmann, K., Cryan, J. F., Wellendorph, P., Mombereau, C., Sansig, G., Klebs, K., Schmutz, M., Froestl, W., Van Der Putten, H., Mosbacher, J., et al. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03013.x · Cited by 184
Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review
McDonough, M., Kennedy, N., Glasper, A., & Bearn, J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.01.012 · Cited by 170
Involvement of drugs in sexual assault.
Slaughter, L. (2000) · PubMed · Cited by 169
Raves: a review of the culture, the drugs and the prevention of harm.
Weir, E. (2000) · Europe PMC (PubMed Central) · Cited by 169
Pharmacokinetics and Excretion of Gamma-Hydroxybutyrate (GHB) in Healthy Subjects
Brenneisen, R., ElSohly, M. A., Murphy, T. P., PASSARELLI, J., Russmann, S., Salamone, S. J., & Watson, D. E. (2004) · Journal of Analytical Toxicology · doi:10.1093/jat/28.8.625 · Cited by 164
Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase
Hogema, B. M., Gupta, M., Senephansiri, H., Burlingame, T. G., Taylor, M., Jakobs, C., Schutgens, R. B. H., Froestl, W., Snead, O. C., Diaz-Arrastia, R., et al. (2001) · Nature Genetics · doi:10.1038/ng727 · Cited by 157
Self-citationGamma‐hydroxybutyric acid: an emerging recreational drug
Kam, P. C. A., & Yoong, F. F. Y. (1998) · Anaesthesia · doi:10.1046/j.1365-2044.1998.00603.x · Cited by 153
Interactions Between Recreational Drugs and Antiretroviral Agents
Antoniou, T., & Tseng, A. L.-I. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a447 · Cited by 151
Binding characteristics of γ-hydroxybutyric acid as a weak but selective GABAB receptor agonist
Mathivet, P., Bernasconi, R., de Barry, J., Marescaux, C., & Bittiger, H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00916-8 · Cited by 134
Evidence for a G Protein‐Coupled γ‐Hydroxybutyric Acid Receptor
Snead, O. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751986.x · Cited by 129
Self-citationA Comprehensive Review of MDMA and GHB: Two Common Club Drugs
Teter, C. J., & Guthrie, S. K. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.20.1486.34472 · Cited by 126
Trends in Illicit Drug Emergencies: The Emerging Role of Gamma-Hydroxybutyrate
Miró, Ò., Nogué, S., Espinosa, G., To‐Figueras, J., & Sánchez, M. (2002) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120004400 · Cited by 124
Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?
Bernasconi, R. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01341-3 · Cited by 122
Harrington, R. D., Woodward, J. A., Hooton, T. M., & Horn, J. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.18.2221 · Cited by 121
Effects of GABA agonists on body temperature regulation in GABAB(1)−/− mice
Quéva, C., Bremner‐Danielsen, M., Edlund, A., Ekstrand, A. J., Elg, S., Erickson, S., Johansson, T., Lehmann, A., & Mattsson, J. P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705447 · Cited by 118
SNEADIII, O. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90199-l · Cited by 111
The GABAA receptor gene family: new opportunities for drug development.
Whiting, P. J. (2003) · PubMed · Cited by 109
Vickers, M. (1969) · International Anesthesiology Clinics · doi:10.1097/00004311-196900710-00007 · Cited by 102
??-Hydroxybutyric Acid: Neurobiology and Toxicology of a Recreational Drug
Wong, C. G. T., Chan, K. F. Y., Gibson, K. M., & Snead, O. C. (2004) · Toxicological Reviews · doi:10.2165/00139709-200423010-00002 · Cited by 99
Self-citationIn vivo conversion of γ-aminobutyric acid and 1,4-butanediol to γ-hydroxybutyric acid in rat brain
Snead, O. C., Furner, R. L., & Liu, C. C. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90645-x · Cited by 95
Self-citationγ-butyrolactone and γ-hydroxybutyric acid—II. The pharmacologically active form
Roth, R. H., Delgado, J. M. R., & Giarman, N. J. (1966) · International Journal of Neuropharmacology · doi:10.1016/0028-3908(66)90007-4 · Cited by 94
Poldrugo, F. (1999) · Alcohol and Alcoholism · doi:10.1093/alcalc/34.1.15 · Cited by 84
Gamma Hydroxybutyrate (GHB) and Gamma Butyrolactone (GBL) Withdrawal: Five Case Studies
McDaniel, C. H., & Miotto, K. A. (2001) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2001.10400479 · Cited by 84
Hechler, V., Ratomponirina, C., & Maître, M. (1997) · PubMed · Cited by 83
The ??-Hydroxybutyrate Withdrawal Syndrome
Tarabar, A. F., & Nelson, L. S. (2004) · Toxicological Reviews · doi:10.2165/00139709-200423010-00005 · Cited by 77
Gamma hydroxybutirate use for sexual assault
Varela, M. (2004) · Emergency Medicine Journal · doi:10.1136/emj.2002.002402 · Cited by 74
Castelli, M. P., Ferraro, L., Mocci, I., Carta, F., Carai, M. A. M., Antonelli, T., Tanganelli, S., Cignarella, G., & Gessa, G. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02037.x · Cited by 72
γ-hydroxybutyrate serum levels and clinical syndrome after severe overdose
Sporer, K. A., Chin, R. L., Dyer, J. E., & Lamb, R. (2003) · Annals of Emergency Medicine · doi:10.1067/mem.2003.253 · Cited by 68
Erhardt, S., Andersson, B. A., Nissbrandt, H., & Engberg, G. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005215 · Cited by 68
Carai, M. A. M., Colombo, G., Reali, R., Serra, S., Mocci, I., Castelli, M. P., Cignarella, G., & Gessa, G. L. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01502-9 · Cited by 64
Pentobarbital for severe gamma-butyrolactone withdrawal
Sivilotti, M. L. A., Burns, M. J., Aaron, C. K., & Greenberg, M. J. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.119454 · Cited by 61
Hu, R. Q., Banerjee, P., & Snead, O. C. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00152-5 · Cited by 60
Self-citationMadden, T., & Johnson, S. W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37787-0 · Cited by 60
Chambliss, K. L., & Gibson, K. M. (1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90077-e · Cited by 58
Self-citationGervasi, N., Monnier, Z., Vincent, P., Paupardin‐Tritsch, D., Hughes, S. W., Crunelli, V., & Leresche, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-36-11469.2003 · Cited by 58
Drug craving and positive/negative hedonic brain substrates activated by addicting drugs
Gardner, E. L., & Lowinson, J. H. (1993) · Seminars in Neuroscience · doi:10.1016/s1044-5765(05)80044-2 · Cited by 56
Depolarization‐Evoked Release of γ‐Hydroxybutyrate from Rat Brain Slices
Maître, M., Cash, C., Weissmann, D., & Mandel, P. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11843.x · Cited by 56
GABAB receptor-mediated increase of neurosteroids by γ-hydroxybutyric acid
Barbaccia, M. L., Colombo, G., Affricano, D., Carai, M. A. M., Vacca, G., Melis, S., Purdy, R. H., & Gessa, G. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00026-6 · Cited by 56
From Club Drug to Orphan Drug: Sodium Oxybate (Xyrem) for the Treatment of Cataplexy
Fuller, D. E., & Hornfeldt, C. S. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.10.1205.32756 · Cited by 55
Suspected GHB Overdoses in the Emergency Department
Couper, F. J., Thatcher, J. E., & Logan, B. K. (2004) · Journal of Analytical Toxicology · doi:10.1093/jat/28.6.481 · Cited by 46
Gobaille, S., Schleef, C., Hechler, V., Viry, S., Aunis, D., & Maître, M. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01526-0 · Cited by 43
Street drug abuse leading to critical illness
Mokhlesi, B., Garimella, P., Joffe, A. M., & Velho, V. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2229-1 · Cited by 43
Physostigmine as a Treatment for Gamma-Hydroxybutyrate Toxicity: A Review
Traub, S. J., Nelson, L. S., & Hoffman, R. S. (2002) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120015839 · Cited by 43
Nonfatal Instances of Intoxication with γ-Hydroxybutyrate in the United Kingdom
Elliott, S. P. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200408000-00014 · Cited by 43
GABAA receptor function in the γ-hydroxybutyrate model of generalized absence seizures
Snead, O. C., & Liu, C. C. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90163-w · Cited by 42
Self-citationRen, X., & Módy, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304238200 · Cited by 41
Kuschinsky, W., Suda, S., & Sokoloff, L. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.8 · Cited by 41
γ‐Hydroxybutyrate modulation of glutamate levels in the hippocampus: an in vivo and in vitro study
Ferraro, L., Tanganelli, S., O'Connor, W. T., Francesconi, W. G., Loche, A., Gessa, G. L., & Antonelli, T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00530.x · Cited by 41
1,4 Butanediol and ethanol compete for degradation in rat brain and liver in vitro
Poldrugo, F., & Snead, O. C. (1986) · Alcohol · doi:10.1016/0741-8329(86)90055-8 · Cited by 39
Self-citationSzabo, S. T., Gold, M. S., Goldberger, B. A., & Blier, P. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.013 · Cited by 38
Dependence of rat serum lactonase upon calcium
Roth, R. H., Levy, R. S., & Giarman, N. J. (1967) · Biochemical Pharmacology · doi:10.1016/0006-2952(67)90110-4 · Cited by 34
Sircar, R., & BASAK, A. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.022 · Cited by 34
Evidence for a γ‐hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles
Muller, C. P., Viry, S., Miehe, M., Andriamampandry, C., Aunis, D., & Maître, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00780.x · Cited by 34
Baclofen antagonises intravenous self-administration of γ-hydroxybutyric acid in mice
Fattore, L., Cossu, G., Martellotta, M. C., Deiana, S., & Fratta, W. (2001) · Neuroreport · doi:10.1097/00001756-200107200-00039 · Cited by 32
Medical problems related to recreational drug use at nocturnal dance parties
Sassenbroeck, D. K. V., Calle, P. A., Rousseau, F. M., et al. (2003) · European Journal of Emergency Medicine · doi:10.1097/00063110-200312000-00012 · Cited by 30
Ethanol Potentiates the Toxic Effects of 1,4‐Butanediol
Poldrugo, F., Barker, S. A., Basa, M. K., Mallardi, F., & Snead, O. C. (1985) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1985.tb05589.x · Cited by 29
Self-citationOttani, A., Vergoni, A. V., Saltini, S., Mioni, C., Giuliani, D., Bartiromo, M., Zaffe, D., Botticelli, A. R., Ferrari, A., Bertolini, A., et al. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.072 · Cited by 25
Carai, M. A. M., Agabio, R., Lobina, C., Reali, R., Vacca, G., Colombo, G., & Gessa, G. L. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01553-9 · Cited by 24
Cited by
A continuing challenge: N-heterocyclic carbene-catalyzed syntheses of γ-butyrolactones
Murauski, K. J. R., Jaworski, A. A., & Scheidt, K. A. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00386b · Cited by 354
γ-Aminobutyric acid (GABA) signalling in plants
Ramesh, S. A., Tyerman, S. D., Gilliham, M., & Xu, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2415-7 · Cited by 313
Isolation and recovery of microbial polyhydroxyalkanoates
Kunasundari, B., & Sudesh, K. (2011) · Express Polymer Letters · doi:10.3144/expresspolymlett.2011.60 · Cited by 293
The Mechanistic Classification of Addictive Drugs
Lüscher, C., & Ungless, M. A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030437 · Cited by 255
Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
Leone, M. A., Vigna-Taglianti, F., Avanzi, G., Brambilla, R., & Faggiano, F. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006266.pub2 · Cited by 163
Metadata
- Authors
- Snead, O. C., & Gibson, K. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-06-30
- Volume
- 352
- Issue
- 26
- Pages
- 2721-2732
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3156308640
- Cited by
- 313
- References
- 76
- FWCI
- 29.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.